BioSpace News Archive

The global blepharitis drugs market is expected to post a CAGR of over 5% during the period 2019-2023, according to the latest market research report by Technavio.

Neuropore Therapies, Inc. announced today that it entered into a collaboration with BenevolentAI to evaluate molecular targets implicated in progressive degenerative diseases which were identified through artificial intelligence.

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced the acquisition of a majority equity stake in Cliniclands, an innovative distributor serving dental practices throughout Sweden, Denmark, and Norway.

In a joint announcement today, the leaders of PATH and the Telemedicine and Telehealth Service Provider Summit (SPS) have agreed to have SPS formally incorporated into PATH

AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, in cooperation with Neurocrine Biosciences, Inc. (NASDAQ: NBIX), today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for elagolix

Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced financial results for the three and six months ended June 30, 2019 and highlighted recent corporate updates.

Qfix and Mevion Medical Systems are pleased to announce that a special version of the kVue™ One Proton couch top is now both validated and available on MEVION S250™ Series Proton Therapy Systems.

Creative Medical Technology Holdings, Inc. (OTC: CELZ), a leading clinical-stage biotechnology company focused on Urology, Neurology and Orthopedics using stem cell treatments, today announced business updates regarding OTCQB status and plans for accelerating product adoption.

Special Olympics also announces Jason Teitler as Senior Vice President of

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced it will present four scientific posters and co-sponsor two posters at the 2019 American Association for Clinical Chemistry (AACC) Annual Scientific Meeting & Clinical Lab Expo.